beta-secretase inhibitors (Actelion)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namebeta-secretase inhibitors (Actelion)
Drug Alias Nameb-site amyloid precursor protein cleaving enzyme inhibitors (Actelion)BACE inhibitors (Actelion)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-secretase inhibitorsBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 proteinBeta-secretase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActelion Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActelion Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A